PRICE INQUIRY No. 1 - being conducted as a market assessment study – extension of the deadline for submitting quotations.
In connection with the project titled: “Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological safety”, funded from the state budget by the Medical Research Agency, WZF Polfa S.A. kindly request to submit a quotation for services involving the development and manufacture of an active substance in the form of a modified oligonucleotide – an 18-mer RNA (nusinersen).
go back